About this trial
In view of the known link between pre-eclampsia, overweight/obesity and chronic kidney disease, the aim is to offer for obese and overweight patients to reduce their BMI without reducing lean body mass.
The POPADIPE project will make it possible to limit overweight or obesity by means of nutritional management chosen by the patient (hypocaloric or a dissociated diet). The latter has been the subject of little scientific investigation, particularly in relation to the management of post-pre-eclampsia.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Person affiliated to social security
Free, informed and written consent signed by the participant and the investigator (no later than the day of day of inclusion and before any examination required by the research)
Patient over 18 years of age at the time of inclusion and < 45 years of age
Having had an pre-eclampsia in the last 5 years according to the definitions of the ISSHP 2018
Disqualifiers
Patients with a mental disability or language barrier that prevents them from understanding or consenting to the study
Patients deprived of their liberty by judicial or administrative decision
Patients under psychiatric care
Patients subject to a legal protection measure
Trial design
Parallel
Treatments tested in this trial
Hypocaloric diet
Other interventionHypocaloric diet
Dissociated diet
Other interventionDissociated diet
Treatment groups
Trial outcomes
Primary outcomes
Demonstrate Efficiency of personalised dietary management on weight loss in patients with a history of pre-eclampsia
Efficiency is evaluated by weight measurement
Sponsors and contacts
Click on the lead sponsor to view all of their trials.